Please provide your email address to receive an email when new articles are posted on . Systemic inflammation mediated 17% of the association between psoriasis severity and subclinical atherosclerosis ...
Please provide your email address to receive an email when new articles are posted on . In a Healio video exclusive, Edward V. Loftus Jr., MD, discusses data he presented at the GUILD Conference, ...
Systemic inflammation, long recognized to be associated with an increased risk for cardiovascular (CV) events, has now been labelled “actionable” by the American College of Cardiology (ACC). This ...
Rheumatoid arthritis (RA) disease activity and inflammatory markers are associated with major adverse cardiovascular events (MACEs) in biologic disease-modifying antirheumatic drug (bDMARD) nonusers ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window TTHealthWatch is ...
Atherosclerosis underlies most heart attacks and strokes and is now recognized as a chronic inflammatory disease rather than ...
Basel, Switzerland: In the international CONVINCE trial, presented today (15 May 2024) at the European Stroke Organisation Conference (ESOC) 2024, anti-inflammatory treatment with long-term colchicine ...
Share on Pinterest The FDA’s approval of Lodoco (colchicine) medication for cardiovascular disease could be a game-changer for treatment. andreswd/Getty Images The FDA recently approved the first anti ...
Researchers have identified a new pathway that contributes to cardiovascular disease associated with high levels of niacin, a common B vitamin previously recommended to lower cholesterol. The team ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results